High-mobility group box-1 and alcoholic liver disease
高迁移率族box-1与酒精性肝病
基本信息
- 批准号:10451824
- 负责人:
- 金额:$ 35.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-07-06 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AbbreviationsAblationAdhesionsAffinityAlcoholic Liver DiseasesAlcoholsArchitectureAutomobile DrivingBindingBiological AssayCell Adhesion MoleculesCellsChemotactic FactorsChemotaxisClinical TrialsCoculture TechniquesComplexDisease ProgressionEthanolEventGenerationsGenesGoalsHMGB1 ProteinHepaticHepatocyteIL1R1 geneImmuneImmune responseImmune systemIn VitroIncidenceInfectionInfiltrationInflammationInflammatoryInjuryInterleukin-1 betaKnowledgeKupffer CellsLeadLigandsLiverMediatingMediator of activation proteinMessenger RNAMolecularMusMyeloid CellsNational Institute on Alcohol Abuse and AlcoholismNatural ImmunityOxidesPathogenesisPathogenicityPatientsPatternPattern RecognitionPost-Translational Protein ProcessingProductionProtein IsoformsProteinsProteomicsReceptor ActivationResearchRoleSignal TransductionSourceSterilitySurface Plasmon ResonanceTestingTumor-infiltrating immune cellsValidationWorkalcohol exposurecytokinedesigneffective therapyexperimental studyfeedingin vivoinhibitorintrahepaticknock-downliver injurymacrophagemonocytemouse modelneutrophilnovelnovel therapeuticsnucleocytoplasmic transportoverexpressionpathogenpreventproblem drinkerreceptorreceptor bindingreceptor for advanced glycation endproductsresponsetherapeutic targettissue injury
项目摘要
ABSTRACT
A critical barrier to progress in the field of alcoholic liver disease (ALD) is the lack of knowledge on the key
proinflammatory mediators and the mechanisms whereby they drive liver injury. High-mobility group box-1
(HMGB1) is a damage-associated molecular pattern that communicates and amplifies inflammation to
neighboring cells. Preliminary studies supporting this application reveal that HMGB1 increases, undergoes post-
translational modifications and is secreted in alcoholic patients and mouse models of ALD. We identified that
both hepatocytes and Kupffer cells produce fully reduced and acetylated HMGB1 whereas hepatocytes are the
main source of oxidized HMGB1. We show that conditional ablation of Hmgb1 in hepatocytes or myeloid cells
partially protects while deletion in both prevents inflammation, interleukin-1β (IL1β) production and ALD.
Likewise, knockdown of the HMGB1 receptor for advanced glycation end-products (RAGE) in myeloid cells
protects from ALD. We have identified that oxidized HMGB1 forms a complex with IL1β in alcoholic patients and
in mice. Overall, HMGB1 drives immune cell infiltration, activates NFκB and increases the proinflammatory
cytokine IL1β, all central events for the onset and progression of ALD. While the HMGB1 isoforms appear to
have distinct effects; yet, the precise contribution of each one of them to alcohol-induced inflammation and IL1β
production remains undefined. We believe that the levels of acetylated and oxidized HMGB1 regulate
inflammatory cell infiltration upon alcohol exposure. These isoforms may also drive the expression of the key
NFκB target proinflammatory cytokine IL1β. Since oxidized HMGB1 forms a complex with IL1β, it could be
immunostimulatory and enhance RAGE and/or IL1R signaling. This may be particularly relevant as both
molecules are central to the pathogenesis of ALD. Yet, further understanding is needed on how the isoforms
lead to immune cell infiltration, the key receptor involved, their binding affinity and if they signal per se or via
immunostimulatory complexes with IL1β to drive NFκB induction of Il1β mRNA and ultimately maturation of IL1β
protein in ALD. Our central hypothesis is that the levels of acetylated and oxidized HMGB1 regulate
inflammatory cell infiltration and IL1β production in ALD. Two specific aims are planned to prove this hypothesis.
In Aim 1, we will dissect how the alcohol-mediated increase in the HMGB1 isoforms regulates inflammatory cell
infiltration into the liver. In Aim 2, we will determine the receptor binding affinity of the HMGB1 isoforms and if
they signal per se or form immunostimulatory complexes with IL1β to drive NFκB induction of Il1β mRNA and
maturation of IL1β protein in ALD. Our long-term goal is to dissect the pathogenic role of the HMGB1 isoforms
as potential therapeutic targets to prevent ALD.
摘要
酒精性肝病(ALD)领域进展的一个关键障碍是缺乏对酒精性肝病(ALD)关键因素的了解。
促炎介质及其驱动肝损伤的机制。高迁移率族蛋白B1
(HMGB 1)是一种损伤相关的分子模式,它传递并放大炎症,
相邻的细胞。支持这一应用的初步研究表明,HMGB 1增加,经历后,
在酒精中毒患者和ALD的小鼠模型中分泌。我们发现
肝细胞和库普弗细胞都产生完全还原和乙酰化的HMGB 1,而肝细胞是
氧化型HMGB 1的主要来源。我们发现,在肝细胞或骨髓细胞中条件性切除Hmgb 1,
部分保护,而两者的缺失防止炎症、白细胞介素-1 β(IL 1 β)产生和ALD。
同样,敲低骨髓细胞中晚期糖基化终产物(AGEs)的HMGB 1受体,
保护ALD。我们已经发现,在酒精中毒患者中,氧化的HMGB 1与IL 1 β形成复合物,
对小鼠总体而言,HMGB 1驱动免疫细胞浸润,激活NFκB并增加促炎性细胞因子的表达。
细胞因子IL 1 β,所有ALD发作和进展的中心事件。虽然HMGB 1亚型似乎
具有不同的作用;然而,它们中的每一个对酒精诱导的炎症和IL 1 β的精确贡献
生产尚未确定。我们认为乙酰化和氧化的HMGB 1水平调节了
炎症细胞浸润。这些异构体也可能驱动关键的表达
NFκB靶向促炎细胞因子IL 1 β。由于氧化的HMGB 1与IL 1 β形成复合物,
免疫刺激和增强的IL 1 R和/或IL 1 R信号传导。这可能特别重要,因为
分子是ALD发病机制的核心。然而,还需要进一步了解异构体
导致免疫细胞浸润,涉及的关键受体,它们的结合亲和力,以及它们本身或通过
与IL 1 β形成免疫刺激复合物,驱动NFκB诱导IL 1 β mRNA并最终使IL 1 β成熟
蛋白质ALD我们的中心假设是乙酰化和氧化的HMGB 1水平调节了
ALD中炎性细胞浸润和IL 1 β产生。计划有两个具体目标来证明这一假设。
在目标1中,我们将剖析酒精介导的HMGB 1亚型的增加如何调节炎症细胞,
渗入肝脏在目标2中,我们将确定HMGB 1亚型的受体结合亲和力,
它们本身发出信号或与IL 1 β形成免疫刺激复合物,以驱动NFκB诱导IL 1 β mRNA,
ALD中IL 1 β蛋白的成熟。我们的长期目标是剖析HMGB 1亚型的致病作用
作为预防ALD的潜在治疗靶点。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Intestinal Osteopontin Protects From Alcohol-induced Liver Injury by Preserving the Gut Microbiome and the Intestinal Barrier Function.
- DOI:10.1016/j.jcmgh.2022.06.012
- 发表时间:2022
- 期刊:
- 影响因子:7.2
- 作者:Das, Sukanta;Song, Zhuolun;Han, Hui;Ge, Xiaodong;Desert, Romain;Athavale, Dipti;Komakula, Sai Santosh Babu;Magdaleno, Fernando;Chen, Wei;Lantvit, Daniel;Guzman, Grace;Nieto, Natalia
- 通讯作者:Nieto, Natalia
Danger signals in liver injury and restoration of homeostasis.
- DOI:10.1016/j.jhep.2020.04.033
- 发表时间:2020-10
- 期刊:
- 影响因子:25.7
- 作者:Han H;Desert R;Das S;Song Z;Athavale D;Ge X;Nieto N
- 通讯作者:Nieto N
The Integrated "Multiomics" Landscape at Peak Injury and Resolution From Alcohol-Associated Liver Disease.
- DOI:10.1002/hep4.1793
- 发表时间:2022-01
- 期刊:
- 影响因子:5.1
- 作者:Das S;Ge X;Han H;Desert R;Song Z;Athavale D;Chen W;Gaskell H;Lantvit D;Guzman G;Nieto N
- 通讯作者:Nieto N
High-Mobility Group Box-1 and Liver Disease.
高动力组框1和肝病。
- DOI:10.1002/hep4.1223
- 发表时间:2018-09
- 期刊:
- 影响因子:5.1
- 作者:Gaskell H;Ge X;Nieto N
- 通讯作者:Nieto N
Osteopontin Takes Center Stage in Chronic Liver Disease.
- DOI:10.1002/hep.31582
- 发表时间:2021-04
- 期刊:
- 影响因子:0
- 作者:Song Z;Chen W;Athavale D;Ge X;Desert R;Das S;Han H;Nieto N
- 通讯作者:Nieto N
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Natalia Nieto其他文献
Natalia Nieto的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Natalia Nieto', 18)}}的其他基金
Protective role of OPN-High macrophages in NASH
OPN-High 巨噬细胞在 NASH 中的保护作用
- 批准号:
10752928 - 财政年份:2023
- 资助金额:
$ 35.98万 - 项目类别:
Pathogenic role of a protein complex of liver origin as regulator of a proinflammatory program that drives hepatic and intestinal injury in alcoholic liver disease
肝脏来源的蛋白质复合物作为促炎程序的调节剂的致病作用,该程序驱动酒精性肝病中的肝脏和肠道损伤
- 批准号:
10663785 - 财政年份:2021
- 资助金额:
$ 35.98万 - 项目类别:
Pathogenic role of a protein complex of liver origin as regulator of a proinflammatory program that drives hepatic and intestinal injury in alcoholic liver disease
肝脏来源的蛋白质复合物作为促炎程序的调节剂的致病作用,该程序驱动酒精性肝病中的肝脏和肠道损伤
- 批准号:
10358521 - 财政年份:2021
- 资助金额:
$ 35.98万 - 项目类别:
High-mobility group box-1 and alcoholic liver disease
高迁移率族box-1与酒精性肝病
- 批准号:
10197739 - 财政年份:2018
- 资助金额:
$ 35.98万 - 项目类别:
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
牛奶骨桥蛋白,酒精性肝炎的营养治疗干预措施
- 批准号:
9088188 - 财政年份:2015
- 资助金额:
$ 35.98万 - 项目类别:
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
牛奶骨桥蛋白,酒精性肝炎的营养治疗干预措施
- 批准号:
9025179 - 财政年份:2015
- 资助金额:
$ 35.98万 - 项目类别:
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
牛奶骨桥蛋白,酒精性肝炎的营养治疗干预措施
- 批准号:
8428356 - 财政年份:2012
- 资助金额:
$ 35.98万 - 项目类别:
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
牛奶骨桥蛋白,酒精性肝炎的营养治疗干预措施
- 批准号:
8549929 - 财政年份:2012
- 资助金额:
$ 35.98万 - 项目类别:
Milk osteopontin, a nutritional therapeutic intervention for alcoholic hepatitis
牛奶骨桥蛋白,酒精性肝炎的营养治疗干预措施
- 批准号:
8693890 - 财政年份:2012
- 资助金额:
$ 35.98万 - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
$ 35.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
心房細動に対するPulsed Field Ablationの組織創傷治癒過程を明らかにする網羅的研究
阐明房颤脉冲场消融组织伤口愈合过程的综合研究
- 批准号:
24K11201 - 财政年份:2024
- 资助金额:
$ 35.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
遅延造影心臓MRIによる心房細動Ablation冷却効果の比較:28 vs. 31 mm Cryoballoon
使用延迟对比增强心脏 MRI 比较房颤消融冷却效果:28 毫米与 31 毫米 Cryoballoon
- 批准号:
24K11281 - 财政年份:2024
- 资助金额:
$ 35.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
InSPACE-VT_Development and Validation of Virtual Pace Mapping to Guide Catheter Ablation of Ventricular Tachycardia
InSPACE-VT_虚拟起搏测绘的开发和验证以指导室性心动过速导管消融
- 批准号:
EP/Z001145/1 - 财政年份:2024
- 资助金额:
$ 35.98万 - 项目类别:
Fellowship
CAREER: Heat Penetration Depth and Direction Control with Closed-Loop Device for Precision Ablation
职业:利用闭环装置控制热穿透深度和方向,实现精确烧蚀
- 批准号:
2338890 - 财政年份:2024
- 资助金额:
$ 35.98万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334777 - 财政年份:2024
- 资助金额:
$ 35.98万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334775 - 财政年份:2024
- 资助金额:
$ 35.98万 - 项目类别:
Continuing Grant
Collaborative Research: RUI: Frontal Ablation Processes on Lake-terminating Glaciers and their Role in Glacier Change
合作研究:RUI:湖终止冰川的锋面消融过程及其在冰川变化中的作用
- 批准号:
2334776 - 财政年份:2024
- 资助金额:
$ 35.98万 - 项目类别:
Continuing Grant
Cryo laser-ablation system (157+193nm) with 'triple-quad' plasma mass spectrometer, Cryo-LA-ICPMS/MS
带有“三重四极杆”等离子体质谱仪、Cryo-LA-ICPMS/MS 的冷冻激光烧蚀系统 (157 193nm)
- 批准号:
515081333 - 财政年份:2023
- 资助金额:
$ 35.98万 - 项目类别:
Major Research Instrumentation
MRI: Acquisition of a Laser Ablation - Inductively Coupled Plasma - Triple Quadrupole - Mass Spectrometer (LA-ICP-QQQ-MS) System For Research and Education
MRI:获取用于研究和教育的激光烧蚀 - 电感耦合等离子体 - 三重四极杆 - 质谱仪 (LA-ICP-MS/MS) 系统
- 批准号:
2320040 - 财政年份:2023
- 资助金额:
$ 35.98万 - 项目类别:
Standard Grant